Developing drugs to treat osteoporosis: lessons learned? (2010)
- Authors:
- Autor USP: PAULA, FRANCISCO JOSE ALBUQUERQUE DE - FMRP
- Unidade: FMRP
- DOI: 10.1517/14656560903575662
- Subjects: OSTEOPOROSE (TRATAMENTO); FÁRMACOS
- Language: Inglês
- Source:
- Título: Expert Opinion on Pharmacotherapy
- ISSN: 1465-6566
- Volume/Número/Paginação/Ano: v. 11, n. 5, p. 867-869, 2010
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PAULA, Francisco Jose Albuquerque de e ROSEN, Clifford J. Developing drugs to treat osteoporosis: lessons learned?. Expert Opinion on Pharmacotherapy, v. 11, n. 5, p. 867-869, 2010Tradução . . Disponível em: https://doi.org/10.1517/14656560903575662. Acesso em: 26 jan. 2026. -
APA
Paula, F. J. A. de, & Rosen, C. J. (2010). Developing drugs to treat osteoporosis: lessons learned? Expert Opinion on Pharmacotherapy, 11( 5), 867-869. doi:10.1517/14656560903575662 -
NLM
Paula FJA de, Rosen CJ. Developing drugs to treat osteoporosis: lessons learned? [Internet]. Expert Opinion on Pharmacotherapy. 2010 ; 11( 5): 867-869.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1517/14656560903575662 -
Vancouver
Paula FJA de, Rosen CJ. Developing drugs to treat osteoporosis: lessons learned? [Internet]. Expert Opinion on Pharmacotherapy. 2010 ; 11( 5): 867-869.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1517/14656560903575662 - Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-ter GH treatment on bone in adults with a mutation in the GHRH-receptor gene
- Comportamento metabolico do tecido muscular em individuos com hiperprolactinemia e em mulheres com hiperandrogenismo por hiperplasia adrenal congenita
- VDR haploinsuficiency impacts body composition and skeletal acquisition in a gender-specific manner
- Osteoporosis
- Heterozygosity in the VTR gene influences body composition more than bone mass
- Influence of primary hypoparathyroidism (PHp) on bone mineral density (BMD) and vertebral morphometry
- Effect of treatment with depot GH on bone remodeling and heel ultrasonometry in Dwarfism due to mutation in the GHRH-R gene
- The consequences of growth hormone-releasing hormone receptor haploinsufficiency for bone quality and insulin resistance
- Trabecular bone loss after admistration of the second-generation antipsychotic risperidone is independent of weight gain
- Deficiência isolada do hormônio de crescimento e metabolismo ósseo
Informações sobre o DOI: 10.1517/14656560903575662 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
